Patients with schizophrenia have increased mortality and morbidity compared with the
general population. These patients have a 20-year shorter lifespan than peers without …

The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision.
Therefore, the search of biomarkers is a fundamental aspect in psychiatry to reach a more …

Antipsychotic medications are critical to child and adolescent psychiatry, from the
stabilization of psychotic disorders like schizophrenia, bipolar disorder, and psychotic …

Metabolic syndrome (MetS) is a cluster of factors that increases the risk of cardiovascular
disease (CVD), one of the leading causes of mortality in patients with schizophrenia …

The therapeutic benefits of the current medications for patients with psychiatric disorders
contrast with a great variety of adverse effects. The endocannabinoid system (ECS) …

Genetic polymorphism in olanzapine-metabolizing enzymes, transporters and drug targets is
associated with alterations in safety and efficacy. The aim of this systematic review is to …

Schizophrenia is characterized by marked language deficits, but it is not clear how these
deficits arise from the alteration of genes related to the disease. The goal of this paper is to …

The purpose of this cross‐sectional study was to investigate whether aerobic fitness
contributes to the health‐related quality of life (HRQ o L) in people with schizophrenia, while …

Clozapine is, and will remain in the coming years, an irreplaceable drug in psychiatry which
has elective indication in treatment-resistant schizophrenia, suicide risk in schizophrenia …

Background The endogenous cannabinoid system mediates the psychoactive effects of
cannabis in the brain. It has been argued that this system may play a key role in the …